Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2018 | -25.54M |
| September 30, 2018 | 11.35M |
| June 30, 2018 | 10.16M |
| March 31, 2018 | 8.442M |
| December 31, 2017 | -19.67M |
| September 30, 2017 | 9.296M |
| June 30, 2017 | 7.073M |
| March 31, 2017 | 7.763M |
| December 31, 2016 | 10.10M |
| September 30, 2016 | 7.046M |
| June 30, 2016 | 8.32M |
| March 31, 2016 | 7.808M |
| December 31, 2015 | 5.021M |
| Date | Value |
|---|---|
| September 30, 2015 | 2.716M |
| June 30, 2015 | 2.821M |
| March 31, 2015 | 1.754M |
| December 31, 2014 | 2.255M |
| September 30, 2014 | 3.634M |
| June 30, 2014 | 1.837M |
| March 31, 2014 | 0.227M |
| December 31, 2013 | 0.0619M |
| September 30, 2013 | 0.1225M |
| June 30, 2013 | 0.2452M |
| March 31, 2013 | 0.114M |
| December 31, 2012 | 0.0363M |
| September 30, 2012 | 0.0771M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| XOMA Corp | 0.025M |
| Ironwood Pharmaceuticals Inc | 35.68M |
| CymaBay Therapeutics Inc (DELISTED) | 22.75M |
| Homology Medicines Inc (DELISTED) | 1.513M |
| Amgen Inc | 1.343B |